News MSD ordered to pull injectable Keytruda from sale in Europe MSD has been rocked by a court judgment ordering it to stop making and selling subcutaneous Keytruda in eight European markets.
News European biotech leaders say optimism is returning Senior figures in European biopharma think dealmaking and M&A will increase in the region, and could be helped by US policy uncertainties.
News UK watchdog takes first action on oral weight drug adverts Online pharmacies operating in the UK breached Advertising Standards Authority rules by promoting oral weight drugs to the public.
News Adecto, Aviceda wind down, as Caribou seeks options There may be a fairly buoyant operating environment for biotechs in the US, but Adecto and Aviceda are winding down, while Caribou is in peril.
News ViiV's Cabenuva enhances control of unsuppressed HIV ViiV's long-acting injectable HIV drug, Cabenuva, has proved to be more effective than daily oral therapy for unsuppressed infections.
News Click claims FDA okay for first-in-class schizophrenia DTx Click Therapeutics has won the first-ever FDA approval for a treatment for the negative symptoms of schizophrenia, a DTx called Motivista.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.